Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × osimertinib × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 152 Lung Neoplasms 48 NSCLC 11 Neoplasms 9 Neoplasm Metastasis 9 Brain Neoplasms 7 Carcinoma 6 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Neoplasms by Site 3 Meningeal Carcinomatosis 3 Lung Diseases 3 Colorectal Neoplasms 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2 Neoplasms, Nerve Tissue 2 Neoplasms by Histologic Type 2 Carcinoma, Squamous Cell 2 Carcinoma, Bronchogenic 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 T790M Positive NSCLC Patients 1 Stage II-IIIB Non-small Cell Lung Carcinoma 1

Interventions

Etoposide 137 Carboplatin 127 Cisplatin 95 Topotecan 68 durvalumab 50 atezolizumab 42 Irinotecan 42 pembrolizumab 32 Radiotherapy 30 Nivolumab 29 Paclitaxel 28 PM 01183 22 Drug Therapy 22 anlotinib 19 apatinib 18 Gemcitabine 18 Ipilimumab 17 Platinum 16 Docetaxel 15 olaparib 13 Radiosurgery 13 Bevacizumab 13 Pemetrexed 12 toripalimab 11 rovalpituzumab tesirine 11 Magnetic Resonance Spectroscopy 11 amrubicin 10 Temozolomide 10 trilaciclib 9 tremelimumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡